Molecular Partners AG (MOLN)
6.12
+0.76
(+14.18%)
USD |
NASDAQ |
Nov 01, 16:00
6.15
+0.03
(+0.49%)
After-Hours: 20:00
Molecular Partners Total Liabilities (Quarterly): 16.74M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 16.74M |
| March 31, 2024 | 18.91M |
| December 31, 2023 | 26.10M |
| September 30, 2023 | 23.95M |
| June 30, 2023 | 27.26M |
| March 31, 2023 | 24.49M |
| December 31, 2022 | 29.22M |
| September 30, 2022 | 30.49M |
| June 30, 2022 | 35.02M |
| March 31, 2022 | 51.28M |
| December 31, 2021 | 71.52M |
| September 30, 2021 | 55.58M |
| June 30, 2021 | 78.56M |
| December 31, 2020 | 91.94M |
| June 30, 2020 | 44.50M |
| December 31, 2019 | 52.43M |
| Date | Value |
|---|---|
| June 30, 2019 | 58.16M |
| June 30, 2019 | 58.16M |
| December 31, 2018 | 64.45M |
| June 30, 2018 | 11.12M |
| June 30, 2018 | 11.12M |
| December 31, 2017 | 28.43M |
| June 30, 2017 | 44.75M |
| June 30, 2017 | 44.75M |
| December 31, 2016 | 47.47M |
| June 30, 2016 | 60.41M |
| June 30, 2016 | 60.41M |
| December 31, 2015 | 68.39M |
| June 30, 2015 | 54.56M |
| June 30, 2015 | 54.56M |
| December 31, 2014 | 46.05M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
16.74M
Minimum
Jun 2024
91.94M
Maximum
Dec 2020
42.37M
Average
32.75M
Median
Total Liabilities (Quarterly) Benchmarks
| AC Immune SA | 126.94M |
| CRISPR Therapeutics AG | 358.90M |
| Addex Therapeutics Ltd | 1.164M |
| NLS Pharmaceutics Ltd | 10.46M |
| MoonLake Immunotherapeutics | 14.85M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 189.80M |
| Shareholders Equity (Quarterly) | 173.06M |
| Current Ratio | 14.58 |